Namouni Fouad

Namouni Fouad is listed in filings as PRESIDENT at Blueprint Medicines Corporation. This profile follows SEC Form 4 activity through Jul 21, 2025, including sale activity. Recent filings connect the profile to Blueprint Medicines Corporation (BPMC) and Vor Biopharma Inc. (VOR). The current snapshot covers public activity from Oct 4, 2024 to Jul 21, 2025. Reported amounts are shown as $6.1M to $2.6M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.